BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37471110)

  • 21. Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia.
    Genescà E; Morgades M; Montesinos P; Barba P; Gil C; Guàrdia R; Moreno MJ; Martínez-Carballeira D; García-Cadenas I; Vives S; Ribera J; González-Campos J; González-Gil C; Zamora L; Ramírez JL; Díaz-Beya M; Mercadal S; Artola MT; Cladera A; Tormo M; Bermúdez A; Vall-Llovera F; Martínez P; Amigo ML; Monsalvo S; Novo A; Cervera M; García-Guiñon A; Juncà J; Ciudad J; Orfao A; Ribera JM
    Haematologica; 2020 Jun; 105(6):e294-e297. PubMed ID: 31537688
    [No Abstract]   [Full Text] [Related]  

  • 22. Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia.
    Heltemes-Harris LM; Larson JD; Starr TK; Hubbard GK; Sarver AL; Largaespada DA; Farrar MA
    Oncogene; 2016 Jun; 35(26):3454-64. PubMed ID: 26500062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute lymphoblastic leukemia with T + PH1 monocytosis: a case report].
    Braham Jmili N; Sendi H; Khelif A
    Ann Biol Clin (Paris); 2011; 69(4):473-5. PubMed ID: 21896415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
    Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
    J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Qu S; Jia Y; Wang H; Ai X; Xu Z; Qin T; Pan L; Li B; Huang G; Gale RP; Xiao Z
    Leuk Lymphoma; 2021 Jun; 62(6):1506-1509. PubMed ID: 33410350
    [No Abstract]   [Full Text] [Related]  

  • 26. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
    Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
    Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
    Dorfman DM; Morgan EA; Pelton A; Unitt C
    Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.
    Fulcher J; Berardi P; Christou G; Villeneuve PJA; Bredeson C; Sabloff M
    Leuk Lymphoma; 2021 Sep; 62(9):2295-2297. PubMed ID: 33749497
    [No Abstract]   [Full Text] [Related]  

  • 29. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
    Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
    Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
    Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
    Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review.
    Zhao Y; Jiang S; Tang Y; Zhao L
    Int J Hematol; 2023 Oct; 118(4):483-488. PubMed ID: 37269505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
    Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma from Multicenter].
    Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.
    Minieri V; De Dominici M; Porazzi P; Mariani SA; Spinelli O; Rambaldi A; Peterson LF; Porcu P; Nevalainen MT; Calabretta B
    Cancer Res; 2018 Oct; 78(20):5793-5807. PubMed ID: 30154155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early T-cell precursor acute lymphoblastic leukemia with Auer rods in mature granulocytes.
    Wang Y; Zhang Z; Xi L; Wang H; Dong F
    Int J Lab Hematol; 2022 Apr; 44(2):e52-e54. PubMed ID: 34559445
    [No Abstract]   [Full Text] [Related]  

  • 38. T-cell acute lymphoblastic leukemia.
    Chiaretti S; Foà R
    Haematologica; 2009 Feb; 94(2):160-2. PubMed ID: 19181788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-lymphoblastic leukaemia/lymphoma with rosettes and gland-like structures.
    Yang Y; Juskevicius R
    Br J Haematol; 2020 Oct; 191(2):141. PubMed ID: 32634863
    [No Abstract]   [Full Text] [Related]  

  • 40. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.